Reduced Kidney Function, Albuminuria, and Risks for All-cause and Cardiovascular Mortality in China: A

Jinwei Wang1,2,3,4, Fang Wang1,2,3,4, Shiwei Liu1,2,3,4,5

  • 1Renal Division, Department of Medicine, Peking University First Hospital, 8 Xishiku Street, Xicheng District, Beijing, China.

BMC Nephrology
|June 9, 2017
PubMed

Insights

Albuminuria significantly increases mortality risk in Chinese adults, while reduced kidney function

Area of Science:

  • Nephrology
  • Epidemiology
  • Public Health

Background:

  • Reduced kidney function and albuminuria are linked to higher mortality and cardiovascular risks.
  • Evidence from Asian populations regarding these risks is limited.
  • This study investigated chronic kidney disease (CKD) indicators and mortality in China.

Purpose of the Study:

  • To examine the association between CKD indicators (eGFR and ACR) and all-cause mortality.
  • To assess the link between CKD indicators and cardiovascular mortality.
  • To provide insights into CKD risks within the Chinese general population.

Main Methods:

  • An observational study of 47,204 Chinese adults.
  • Cross-sectional survey data with survival status tracked until December 31, 2013.
  • Estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (ACR) were used as CKD indicators.

Main Results:

  • Both all-cause and cardiovascular mortality rates increased with reduced eGFR or elevated ACR.
  • Elevated ACR was significantly associated with increased all-cause and cardiovascular mortality risk.
  • Reduced eGFR was not a clear predictor, but its association with mortality was prominent in those under 65.

Conclusions:

  • Albuminuria is linked to increased all-cause and cardiovascular mortality in the Chinese population.
  • The association between reduced kidney function and all-cause mortality requires further clarification.
  • Albuminuria serves as a significant mortality risk indicator in this population.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
801
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
863
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
283
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
391
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
529
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
288